Andrew Wei, MBBS, PhD^1,2, Gail J. Roboz, MD³, Hervé Dombret, MD^4,5, Hartmut Döhner⁶, Andre C. Schuh^7,8, Pau Montesinos, MD, PhD^9,10*, Christopher Pocock, MBBS¹¹, Dominik Selleslag, MD¹², Sergey N. Bondarenko^13*, Ignazia La Torre^14*, Barry Skikne, MD^15,16*, Keshava Kumar, PhD^16*, Qian Dong, DrPH^16*, C.L. Beach, PharmD^16* and Farhad Ravandi, MBBS¹⁷

¹Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia
²Monash University, Australian Centre for Blood Diseases, Melbourne, Australia
³Weill Medical College of Cornell University New York-Presbyterian Hospital, New York, NY
⁴Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, France
⁵Institut de Recherche Saint Louis, Université de Paris, Paris, France
⁶Ulm University Hospital, Ulm, Germany
⁷University of Toronto, Toronto, Canada
⁸Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
¹⁰Hospital Universitario y Politécnico La Fe, Valencia, Spain
¹¹Kent & Canterbury Hospital, Canterbury, United Kingdom
¹²AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium
¹³RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
¹⁴Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
¹⁵Kansas University Medical Center, Kansas City, KS
¹⁶Bristol Myers Squibb, Princeton, NJ
¹⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Amer M. Zeidan, MBBS, MHS¹, Pierre Fenaux, MD, PhD², Marco Gobbi, MD^3*, Jiri Mayer^4*, Gail J. Roboz, MD⁵, Jürgen Krauter, MD^6*, Tadeusz Robak, MD PhD⁷, Jan Philipp Bewersdorf, MD⁸, Hagop M. Kantarjian, MD⁹, Jan Novak^10*, Wieslaw Wiktor Jedrzejczak, MD, PhD^11*, Xavier Thomas, MD, PhD¹², Mario Ojeda-Uribe^13*, Yasushi Miyazaki, MD, PhD¹⁴, Yoo Hong Min, MD, PhD¹⁵, Su-Peng Yeh, MD^16*, Joseph M Brandwein, MD¹⁷, Liana Gercheva, MD^18*, Judit Demeter, MD^19*, Elizabeth A. Griffiths, MD²⁰, Karen W.L. Yee, MD²¹, Jean-Pierre Issa, MD^22*, Yong Hao, MD, PhD^23*, Mohammad Azab, MD, MSc, MBA^24* and Hartmut Döhner²⁵

¹Yale University School of Medicine and Yale Cancer Center, New Haven, CT
²Hôpital Saint-Louis, Paris, France
³IRCCS Ospedale Policlinico San Martino, Genoa, Italy
⁴University Hospital Brno, Czech Republic, Brno, CZE
⁵Weill Medical College of Cornell University New York-Presbyterian Hospital, New York, NY
⁶Department of Internal Medicine III, Städtisches Klinikum Braunschweig, Braunschweig, Germany
⁷Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
⁸Department of Internal Medicine, Yale University, New Haven, CT
⁹The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic
¹¹Uniwersyteckie Centrum Kliniczne WUM, Warsaw, Poland
¹²Centre Hospitalier Universitaire de Lyon-Sud, Lyon, France
¹³GHR Mulhouse Sud-Alsace, Mulhouse, France
¹⁴Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan
¹⁵Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of (South)
¹⁶Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
¹⁷Division of Hematology, University of Alberta, Edmonton, AB, Canada
¹⁸Clinical Hematology Clinic, Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Bulgaria
¹⁹Semmelweis University, Budapest, HUN
²⁰Roswell Park Comprehensive Cancer Center, Buffalo, NY
²¹Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²²Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA
²³Astex Pharmaceuticals, Inc., Pleasanton, CA
²⁴Astex Pharmaceuticals, Inc., Pleasanton, NJ
²⁵Ulm University Hospital, Ulm, Germany

Richard M. Stone, MD¹, Daniel J. DeAngelo, MD, PhD², Anthony G. Letai, MD, PhD³, Jeremy M. Stewart, BA^2*, Michael McGinnis^2*, Francis Brown, JD^2*, Geoffrey Fell^4*, Yael Flammand^5*, Marina Konopleva, MD, PhD⁶, Jacqueline S. Garcia, MD² and Marlise R Luskin, MD, MS¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute & HMS, Boston, MA
⁴Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Biostatistics, Dana-Farber Cancer Institute, Boston, MA
⁶University of Texas, MD Anderson Cancer Center, Houston, TX

Gail J. Roboz, MD¹, Daniel J. DeAngelo, MD, PhD², David A. Sallman, MD³, Monica L. Guzman, PhD⁴, Pinkal Desai, MD, MPH⁵, Hagop M. Kantarjian, MD⁶, Marina Konopleva, MD, PhD⁷, Nelli Bejanyan, MD⁸, Hany Elmariah, MD, MS⁹, Francisco Javier Esteva, MD, PhD^10*, Andrew Garton^11*, Kate Backhouse^10*, Roman Galetto, PhD^12*, Carrie Brownstein, MD¹⁰ and Naveen Pemmaraju, MD¹³

¹Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY
²Department of Medical Oncology, Dana-Farber Cancer Inst., Boston, MA
³H. Lee Moffitt Cancer Center, Tampa, FL
⁴Division of Hematology and Oncology, Weill Cornell Medical College Division of Hematology/Oncology, New York, NY
⁵Weill Cornell Medical College, New York, NY
⁶University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁰Cellectis, New York, NY
¹¹Cellectis Inc, New York
¹²Cellectis SA, Paris, France
¹³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Carlos Bachier, MD¹, Gautam Borthakur, MD², Chitra Hosing, MD³, William Blum, MD^4*, Marcello Rotta, MD⁵, Paulius Ojeras^6*, Brian Barnett, MD^6*, Kanya Rajangam, MD, PhD^6*, Navneet S. Majhail, MD, MS⁷ and Sarah Nikiforow, MD, PhD^8*

¹Sarah Cannon Blood Cancer Network, Sarah Cannon Center for Blood Cancer, Nashville, TN
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX
⁴Winship Cancer Institute of Emory University, Atlanta, GA
⁵Sarah Cannon Blood Cancer Network, Colorado Blood Cancer Institute, Denver, CO
⁶Nkarta Therapeutics, South San Francisco, CA
⁷Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Naval Daver, MD¹, Sreyashi Basu, PhD^2*, Guillermo Garcia-Manero, MD³, Hussein A Abbas, MD, PhD⁴, Marina Konopleva, MD, PhD⁵, Tapan M. Kadia, MD⁶, Courtney D. DiNardo, MD, MSc⁷, Gautam Borthakur, MD³, Ahmad S. Alotaibi, MD^1*, Naveen Pemmaraju, MD³, Elias Jabbour, MD³, Sherry A. Pierce, BSN, BA^3*, Mark Brandt, BS^3*, Koichi Takahashi, MD, PhD⁸, Jing Ning^9*, Steven M. Kornblau, MD¹⁰, Koji Sasaki, MD¹¹, Musa Yilmaz, MD¹¹, Ghayas C. Issa, MD¹², Nicholas J. Short, MD³, Jairo A. Matthews^13*, Wilmer Flores^14*, Michael Andreeff, MD, PhD¹⁵, Jorge E. Cortes, MD¹⁶, Farhad Ravandi, MBBS¹⁷, James P Allison, PhD^2*, Hagop M. Kantarjian, MD¹⁸ and Padmanee Sharma^19*

¹Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
²Department of Immunology, UT M. D. Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Division of Cancer Medicine, Medical Oncology Fellowship, UT M. D. Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁸Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Stem Cell Transplantation, M.D. Anderson Cancer Center University of Texas, Houston, TX
¹¹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
¹²Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
¹³Department of Leukemia, UT M. D. Anderson Cancer Center, Houston, TX
¹⁴Leukemia, University of Texas - MD Anderson Cancer Center, Houston, TX
¹⁵Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁶Georgia Cancer Center Augusta University, Augusta, GA
¹⁷Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
¹⁸Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁹Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Rafael Bejar, MD, PhD^1,2, Hongying Zhang, MD, PhD^1*, Nasrin Rastgoo, PhD^1*, Khalid Benbatoul, BS^1*, Yuying Jin, PhD^1*, Matthew Thayer, BS.^1*, Susan Sheng, PhD^1*, Gregory k Chow, BA, MBA^3*, Victor Montalvo-Lugo^1*, Jotin Marango, MD^1*, Stephen B Howell, MD² and William G Rice, PhD¹

¹Aptose Biosciences, Inc., San Diego, CA
²Moores Cancer Center, University of California San Diego, La Jolla, CA
³Aptose Biosciences Inc., Burlingame, CA

Verena I Gaidzik, MD¹, Verena Mayr-Benedikter^1*, Daniela Weber, MSc^1*, Anika Schrade, PhD^1*, Jürgen Krauter, MD^2*, Juliane S. Walz, MD^3*, Holger Hebart, MD⁴, Beate S. Schultheis, MD⁵, Nadezda Basara, MD⁶, Elisabeth Dietl, MD^7*, Silke Kapp-Schwoerer, MD^1*, Michaela Feuring-Buske, MD^1*, Felicitas Thol⁸, Michael Heuser⁸, Stefan Faderl, MD^9*, Anthony J. Wagner^9*, Maral Saadati^10*, Julia Krzykalla, PhD^11*, Axel Benner^11*, Arnold Ganser⁸, Konstanze Dohner, MD¹, Peter Paschka, MD¹ and Hartmut Döhner¹

¹Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany
²Medizinische Klinik III, Städtisches Klinikum Braunschweig, Braunschweig, Germany
³Klinik für Innere Medizin II, Universitätsklinikum Tübingen, Tübingen, Germany
⁴Stauferklinikum Mutlangen, Ostalb Kliniken, Mutlangen, Germany
⁵Medizinische Klinik III - Hämatologie / Onkologie, Marienhospital Herne, Herne, Germany
⁶Medizinische Klinik I, Malteser Krankenhaus St. Franziskus-Hospital, Flensburg, Germany
⁷Hämatologie und Onkologie und Palliativmedizin, Klinikum Traunstein, Traunstein, Germany
⁸Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany
⁹Jazz Pharmaceuticals, Palo Alto, CA
¹⁰Saadati Solutions, Ladenburg, Germany
¹¹Abteilung für Biostatistik, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany

Leanne Lanieri^1*, Tahirih L Lamothe, BS^1*, Oliver Miske^1*, Sean M McDonough^2*, Ganapathy N Sarma^1*, Prashant Bhattarai^1*, Kellie Latimer^1*, Junia Dushime^1*, Nidhi Jain^1*, Rahul Palchaudhuri, PhD^1*, Ryan Knihtila^1*, Bradley R Pearse, PhD^1*, Jennifer L Proctor, BS^1*, Anthony E Boitano, PhD¹, Michael P Cooke, PhD¹ and John C. Davis Jr., MD, MPH, MS^1*

¹Magenta Therapeutics, Cambridge, MA
²Magenta Therapeutics, Wakefield, MA

Joshua F. Zeidner, MD¹, Daniel J. Lee, MD², Gil Fine, PhD^3*, Eunice S. Wang, MD⁴, Vijaya R. Bhatt, MD⁵, Andrew Dalovisio, MD^6*, Pau Montesinos, MD, PhD^7*, Kathryn S. Kolibaba, MD³, Stephen P. Anthony, DO³, David J. Bearss, PhD³ and B. Douglas Smith, MD⁸

¹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
³Sumitomo Dainippon Pharma Oncology, Inc., Lehi, UT
⁴Roswell Park Comprehensive Cancer Center, BUFFALO, NY
⁵Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
⁶Ochsner Medical Center, New Orleans, LA
⁷Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain
⁸Johns Hopkins Medical Institutes, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Kana Nakatani^1*, Hidemasa Matsuo^2*, Yutarou Harata^3*, Moe Higashitani^4*, Asami Koyama^3*, Mina Noura^5*, Yoko Nishinaka-Arai, PhD^2,6*, Yasuhiko Kamikubo^3* and Souichi Adachi, MD, PhD³

¹Department of Human Health Sciences, Kyoto University, Kyoto-Shi, Japan
²Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto City, Japan
³Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁴Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, JPN
⁵Department of Human Health Sciences, Kyoto University, Kyoto, Japan
⁶Center for iPS cell Research and Application, Center For Ips Cell Research and Application, Kyoto City, Japan

Naval Daver, MD¹, Kendra L. Sweet, MD, MS^2*, Pau Montesinos, MD, PhD^3*, Eunice S. Wang, MD⁴, Ahmed Aribi, MD^5*, Daniel J. DeAngelo, MD, PhD⁶, Harry P Erba, MD PhD⁷, Giovanni Martinelli, MD⁸, Roland P Walter, MD PhD⁹, Jessica K Altman, MD¹⁰, Anjali S Advani, MD¹¹, Antonio Curti, MD PhD¹², Callum M Sloss, PhD¹³, Kara E Malcolm, RN^13* and Patrick A Zweidler-McKay, MD, PhD¹⁴

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁴Roswell Park Comprehensive Cancer Center, BUFFALO, NY
⁵City of Hope National Medical Center, Duarte, CA
⁶Department of Medical Oncology, Dana-Farber Cancer Inst., Boston, MA
⁷Duke University School of Medicine, Durham, NC
⁸Institute of Hematology “L. e A. Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy
⁹Department of Medicine, University of Washington, Seattle, WA
¹⁰Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
¹¹Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
¹²Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy
¹³ImmunoGen, Waltham, MA
¹⁴ImmunoGen, Lincoln, MA

Daria Frank^1*, Ashok Kumar Jayavelu, PhD^2*, Lanying Wei, M.Sc.^1,3*, Yahya Saleh Al-Matary, PhD^4*, Pradeep Kumar Patnana, M.Sc.^1*, Subbaiah Chary Nimmagadda, PhD^1*, Michael Heuser, Prof., MD^5*, Felicitas Thol⁶, Gudrun Gohring, Prof., MD^7*, Jürgen Thomale, PhD^8*, Anja Pfaus, M.Sc.^9*, Roland Rad, Prof., MD^9*, Christoph Röllig, Prof., MD^10*, Friedrich Stoelzel, PD, MD¹¹, Claudia Dill^11*, Heidi Altmann, PhD^11*, Desiree Kunadt, MD^11*, Christoph Schliemann, Prof., MD^1*, Jan-Henrik Mikesch, PD, MD^1*, Maria Francisca Arteaga, PhD^1*, Wolfgang E. Berdel, Prof., MD¹, Georg Lenz¹ and Cyrus Khandanpour, PD, MD¹

¹Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany
²Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Munich, Bayern, Germany
³Institute of Medical Informatics, Muenster University, Muenster, Germany
⁴Clinic of Dermatology, University Hospital Essen, Essen, Germany
⁵Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁶Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁷Department of Human Genetics, Hannover Medical School, Hannover, Germany
⁸Institute of Cell Biology, University Hospital Essen, Essen, Germany
⁹Institute of Molecular Oncology and Functional Genomics, Technical University of Munich, Munich, Germany
¹⁰Department of Hematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
¹¹Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany

Helal Mohammed Mohammed Ahmed Noman, MBBS¹, Yahya Saleh Al-Matary, PhD^2*, Subbaiah Chary Nimmagadda, PhD^3*, Maren Fiori^4*, Pradeep Kumar Patnana, M.Sc.^3*, Daria Frank^3*, Lanying Wei, M.Sc.^5*, Judith Schütte, PhD^3*, Tobias May^6*, Joachim R. Goethert, MD^4*, Thomas Schroeder, MD^7*, Ulrike Buttkereit, PhD^4*, Christian Recher, MD, PhD⁸, Manuel Rodríguez-Paredes^9*, Thorsten Koenig^10*, Wolfgang Hartmann, MD^11*, Jan Tuckermann, PhD^12*, Bertram Opalka, PhD^4*, Georg Lenz³ and Cyrus Khandanpour, PD, MD³

¹Department of Medicine A, University Hospital Muenster, Münster, Germany
²Clinic of Dermatology, University Hospital Essen, Essen, Germany
³Department of Medicine A, University Hospital Muenster, Muenster, Germany
⁴University Hospital Essen, Essen, Germany
⁵Institute of Medical Informatics, Muenster University, Muenster, Germany
⁶InSCREENeX GmbH, Brunswick, Germany
⁷University Hospital Duesseldorf, Duesseldorf, AL, DEU
⁸Clinical Hematology, ins, Toulouse, France
⁹German Cancer Research Center, Heidelberg, Germany
¹⁰Institute for Molecular Tumor Biology, University of Münster, Muenster, Germany
¹¹Pathology department, University Hospital Muesnter, Muenster, Germany
¹²Institute for Molecular Endocrinology of Animals, Ulm, Germany

Tracy Murphy, MD, FRCP, FRCPath¹, Brian Leber, MD², Mark R Bray^3*, Steven M Chan, MD, PhD¹, Vikas Gupta, MD, FRCP, FRCPath⁴, Dina Khalaf, BSc, MSc, MD², Dawn Maze, MD, FRCPC, MSc¹, Caroline J McNamara, MBBS¹, Aaron D Schimmer, MD, PhD¹, Andre C. Schuh¹, Hassan Sibai, MBBS^1*, Graham Fletcher^3*, Debbie Valiquette^2*, Kylie Martin, BSc, RN, BSN^1*, Mark D. Minden¹ and Karen W.L. Yee, MD⁴

¹Princess Margaret Cancer Centre, Division of Medical Oncology and Hematology, University Health Network, University of Toronto, Toronto, ON, Canada
²Division of Hematology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
³University Health Network, Toronto, ON, Canada
⁴Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Agnieszka Wierzbowska, MD^1*, Agnieszka Pluta, MD PhD^1*, Marta Antonina Libura, MD PhD^2*, Anna Czyz, MD PhD^3*, Sebastian Giebel, MD PhD^4*, Piotr Stelmach, MD PhD^1*, Magdalena Czemerska, MD PhD^5*, Anna Kopinska, MD^6*, Krzysztof Wozniczka, MD PhD^6*, Grzegorz Helbig, MD PhD^6*, Karol Wojcik, MD^7*, Malgorzata Razny, MD PhD^7*, Marta Sobas, MD PhD^3*, Tomasz Wrobel, MD PhD³, Andrzej Szczepaniak, MD PhD^8*, Lidia Gil, MD PhD⁹, Jan Zaucha, MD PhD^10*, Tomasz Gromek, MD PhD^11*, Marek Hus, MD PhD^11*, Edyta Cichocka, MD PhD^12*, Janusz Halka, MD PhD^13*, Elzbieta Patkowska^14*, Jolanta Wozniak, PhD^15*, Agata Obara, MD^16*, Beata Blajer-Olszewska, MD^17*, Katarzyna Dulik, MD^4*, Jerzy Holowiecki, MD PhD^4*, Michal Soin, M.Sc.^1*, Tadeusz Robak, MD PhD¹, Nicole M. Cruz, MD¹⁸, Nuria Mencia-Trinchant, PhD^18*, Pinkal Desai, MD, MPH¹⁹, Sangmin Lee, MD¹⁸, Michael B. Samuel, MD^18*, Maria Bieniaszewska^10*, Magdalena Dutka, MD^10*, Justin D. Kaner, MD¹⁸, Ellen Ritchie, MD ²⁰, Monica L. Guzman, PhD²¹ and Gail J. Roboz, MD²²

¹Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
²Department of Hematology, Oncology and Internal Medicine, Warsaw Medical University, Warsaw, Poland
³Department of Hematology, Wroclaw Medical University, Wroclaw, Poland
⁴Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
⁵Deaprtment of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
⁶Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
⁷Department of Hematology, Rydygier Memorial Hospital, Krakow, Poland
⁸Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Poznan, Poland
⁹Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
¹⁰Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
¹¹Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
¹²Department of Hematology, Copernicus Memorial Hospital, Torun, Poland
¹³Department of Hematology, Warmian-Masurian Cancer Center of The Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland
¹⁴Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹⁵Division of Hematological Diagnostics, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹⁶Department of Hematology, Holly Cross Oncology Center, Kielce, Poland
¹⁷Department of Hematology, Chopin Memorial Teaching Hospital No 1, Rzeszów, Poland
¹⁸Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY
¹⁹Weill Cornell Medical College, New York, NY
²⁰Weill Cornell Medicine, New York, NY
²¹Division of Hematology and Oncology, Weill Cornell Medical College Division of Hematology/Oncology, New York, NY
²²Weill Medical College of Cornell University New York-Presbyterian Hospital, New York, NY

Silvia Maifrede^1*, Bac Viet Le^1*, Margaret Nieborowska-Skorska^1*, Konstantin Golovine^1*, Katherine Sullivan-Reed^1*, Wangisa M.B. Dunuwille^2*, Joseph Nacson^3*, Michael Hulse^1*, Lisa Beatrice Caruso^1*, Zachary Gazze^1*, Zhaorui Lian^1*, Antonella Padella^4*, Kumaraswamy Chitrala^1*, Boris Bartholdy^5*, Ksenia Matlawska-Wasowska^6*, Daniela Di Marcantonio³, Giorgia Simonetti^7*, Georg Greiner^8*, Stephen M. Sykes³, Peter Valent, MD⁹, Elisabeth M. Paietta^10*, Hugo F Fernandez^11*, Martin S. Tallman, MD ¹², Mark Litzow, MD¹³, Mark D. Minden¹⁴, Jian Huang¹, Giovanni Martinelli, MD⁴, George S. Vassiliou, MD, PhD, FRCPath, MRCP^15*, Italo Tempera^1*, Katarzyna Piwocka^16*, Neil Johnson^3*, Grant Challen¹⁷ and Tomasz Skorski, MD, PhD¹

¹Temple University School of Medicine, Philadelphia, PA
²Washington University School of Medicine, Saint Louis
³Fox Chase Cancer Center, Philadelphia, PA
⁴University of Bologna, Meldola, Italy
⁵Albert Einstein College of Medicine, Bronx, NY
⁶University of New Mexico, Albuquerque, NM
⁷University of Bologna, Bologna, Italy
⁸Medical University of Vienna, Vienna, Austria
⁹Department of Medicine I, Division of Hematology, Medical University of Vienna, Vienna, Austria
¹⁰Albert Einstein College of Medicine, New York, NY
¹¹Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Pembroke Pines
¹²Memorial Sloan-Kettering Cancer Center, New York, NY
¹³Division of Hematology, Mayo Clinic, Rochester, MN
¹⁴Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁵Wellcome Trust Sanger Institute, Cambridge, ENG, United Kingdom
¹⁶Nencki Institute of Experimental Biology, Warsaw, Poland
¹⁷Washington University School of Medicine, St Louis, MO

Shaker A Mousa, PhD, MSc, BPharm, MBA^1,2, Noureldien Darwish, MBBCh, PhD³ and Thangirala Sudha, PhD^4*

¹The Pharmaceutical Research Institute, ACPHS, Prof, Rensselaer, NY
²NanoPharmaceuticals LLC, Rensselaer, NY
³The Pharmaceutical Research Institute, ACPHS, Albany, NY
⁴The Pharmaceutical Research Institute, ACPHS, Rensselaer, NY

Jonathan Canaani, MD¹, Ivetta Danilesko, MD^2*, Noga Shem-Tov, MD^3*, Maya Zlotnick, MD^4*, Kira Lozinsky^5*, Ohad Benjamini^4*, Ronit Yerushalmi, MD⁴, Meital Nagar, PhD^6*, Chen Dor, PhD^5*, Avichai Shimoni, MD^7*, Abraham Avigdor, MD⁸ and Arnon Nagler, MD⁹

¹Hematology Division, Sheba Medical Center, Givatayim, Israel
²Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center,, Ramat-Gan, Israel
³Division of Hematology and Bone Marrow Transplantation,, Chaim Sheba Medical Center, Ramat-Gan, Israel
⁴Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
⁵Hematology, Chaim Sheba Medical Center, Ramat Gan, Israel
⁶Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat-Gan, Israel
⁷Division of Hematology, Sheba Medical Center, Ramat Gan, Israel
⁸Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
⁹Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel

Tomasz Zal, PhD, MSc¹, Rafal Zielinski, PhD^2*, Krzysztof Grela, MSc^2*, Roberto Cardenas-Zuniga^2*, Stanislaw Skora, PhD^2*, Izabela Fokt, PhD^2*, Malgorzata Anna Zal, MSc^3*, Michael Andreeff, MD, PhD⁴, Lidia Gil, MD PhD⁵, Robert Shephard, MD, PhD^6* and Waldemar Priebe, PhD^2*

¹Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
⁶Moleculin Biotech, Inc., Houston, TX

Christopher J. Hindley, PhD^1*, Lynsey Fazal, BSc^1*, Joanne M. Munck, PhD^1*, Vanessa Martins, BSc^1*, Alpesh D. Shah, MSci^1*, Nicola E. Wilsher, PhD^1*, Nicola G. Wallis, PhD^1*, Harold N. Keer, MD, PhD² and John F. Lyons, PhD^1*

¹Astex Pharmaceuticals, Cambridge, United Kingdom
²Astex Pharmaceuticals, Inc., Pleasanton, CA

Aaron D Goldberg, MD, PhD¹, Mark B. Geyer, MD², Jonathan Kell, MD³, Eros Di Bona, MD^4*, Timothy S. Pardee, MD, PhD⁵, Rupali Bhave, M.D.^6*, Michael R. Grunwald, MD⁷, Giovanni Marconi, MD⁸, Yijia Wang, MD, MPH^9*, Asif Pathan, PhD, RPh^9* and Boo Messahel, MD^9*

¹Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
²Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom
⁴Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
⁵Comprehensive Cancer Center of Wake Forest Baptist Medical Center, Winston Salem, NC
⁶Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC
⁷Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁸Istituto di Ematologia e Oncologia Medica "Lorenzo e Ariosto Seràgnoli" Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
⁹Arog Pharmaceuticals, Plano, TX

Mike J Donio^*, W. Casey Wilson, PhD^*, Isra Darwech^*, Gabriela Andrejeva, PhD^*, Benjamin J Capoccia, PhD^*, Robyn J Puro, PhD^*, Arun K Kashyap, PhD^* and Daniel S Pereira, PhD

Arch Oncology, St Louis, MO

Jayna J Mistry, BSc^1*, Charlotte Hellmich^2*, Amelia Lambert^3*, Jamie A Moore, BSc, MSc^4*, Aisha Jibril, BSc^5*, Angela Collins, MBBS^6*, Federica Di Palma, PhD^7*, Kristian M Bowles, MBBS, PhD^5,6 and Stuart A Rushworth, PhD⁵

¹Norwich Medical School, The University of East Anglia, Leicester, United Kingdom
²The University of East Anglia, Norwich, GBR
³The University of East Anglia, Norwich, United Kingdom
⁴Norwich Medical School, The University of East Anglia, Attleborough, ENG, United Kingdom
⁵Norwich Medical School, University of East Anglia, Norwich, United Kingdom
⁶Department of Haematology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom
⁷Earlham Institute, Norwich, United Kingdom

Lindsay Wilde, MD, Ubaldo Martinez-Outschoorn, MD^*, Neil Palmisiano, MD, MS, Gina Keiffer, MD and Margaret Kasner, MD, MSc

Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA